Accenture Plc (NYSE:ACN) shares came under pressure in early trading on Friday, even after the company reported upbeat results for its fiscal fourth quarter. The company reported its results amid an exciting earnings season. Here are some key analyst takeaways. Piper Sandler On AccentureAnalyst Arvind Ramnani upgraded the rating from Neutral to Overweight while lifting the price target from $329 to $395. Accenture reported $1 billion in GenAI-related bookings, bringing the total GenAI bookings to $3 billion for fiscal 2024, of which $900 million were converted into revenues during the year, Ra…